UPTRAVI selexipag 1200 microgram film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

uptravi selexipag 1200 microgram film-coated tablet blister pack

janssen-cilag pty ltd - selexipag, quantity: 1200 microgram - tablet, film coated - excipient ingredients: titanium dioxide; hyprolose; maize starch; propylene glycol; iron oxide red; mannitol; hypromellose; magnesium stearate; carnauba wax; iron oxide black - uptravi is indicated for the treatment of:,- idiopathic pulmonary arterial hypertension;,- heritable pulmonary arterial hypertension;,- pulmonary arterial hypertension associated with connective tissue disease;,-pulmonary arterial hypertension associated with congenital heart disease with repaired shunts;,-pulmonary arterial hypertension associated with drugs and toxins;,in patients with who functional class ii, iii or iv symptoms

UPTRAVI selexipag 1000 microgram film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

uptravi selexipag 1000 microgram film-coated tablet blister pack

janssen-cilag pty ltd - selexipag, quantity: 1000 microgram - tablet, film coated - excipient ingredients: mannitol; hypromellose; titanium dioxide; maize starch; hyprolose; magnesium stearate; propylene glycol; iron oxide red; carnauba wax; iron oxide yellow - uptravi is indicated for the treatment of:,- idiopathic pulmonary arterial hypertension;,- heritable pulmonary arterial hypertension;,- pulmonary arterial hypertension associated with connective tissue disease;,-pulmonary arterial hypertension associated with congenital heart disease with repaired shunts;,-pulmonary arterial hypertension associated with drugs and toxins;,in patients with who functional class ii, iii or iv symptoms

UPTRAVI selexipag 200 microgram film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

uptravi selexipag 200 microgram film-coated tablet blister pack

janssen-cilag pty ltd - selexipag, quantity: 200 microgram - tablet, film coated - excipient ingredients: iron oxide yellow; carnauba wax; maize starch; magnesium stearate; hyprolose; propylene glycol; mannitol; titanium dioxide; hypromellose - uptravi is indicated for the treatment of:,- idiopathic pulmonary arterial hypertension;,- heritable pulmonary arterial hypertension;,- pulmonary arterial hypertension associated with connective tissue disease;,-pulmonary arterial hypertension associated with congenital heart disease with repaired shunts;,-pulmonary arterial hypertension associated with drugs and toxins;,in patients with who functional class ii, iii or iv symptoms

UPTRAVI selexipag 400 microgram film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

uptravi selexipag 400 microgram film-coated tablet blister pack

janssen-cilag pty ltd - selexipag, quantity: 400 microgram - tablet, film coated - excipient ingredients: hyprolose; hypromellose; carnauba wax; magnesium stearate; mannitol; maize starch; propylene glycol; titanium dioxide; iron oxide red - uptravi is indicated for the treatment of:,- idiopathic pulmonary arterial hypertension;,- heritable pulmonary arterial hypertension;,- pulmonary arterial hypertension associated with connective tissue disease;,-pulmonary arterial hypertension associated with congenital heart disease with repaired shunts;,-pulmonary arterial hypertension associated with drugs and toxins;,in patients with who functional class ii, iii or iv symptoms

UPTRAVI selexipag 600 microgram film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

uptravi selexipag 600 microgram film-coated tablet blister pack

janssen-cilag pty ltd - selexipag, quantity: 600 microgram - tablet, film coated - excipient ingredients: iron oxide red; hyprolose; carnauba wax; magnesium stearate; titanium dioxide; hypromellose; propylene glycol; mannitol; maize starch; iron oxide black - uptravi is indicated for the treatment of:,- idiopathic pulmonary arterial hypertension;,- heritable pulmonary arterial hypertension;,- pulmonary arterial hypertension associated with connective tissue disease;,-pulmonary arterial hypertension associated with congenital heart disease with repaired shunts;,-pulmonary arterial hypertension associated with drugs and toxins;,in patients with who functional class ii, iii or iv symptoms

Hemani Fluroxypyr 200 EC Herbicide Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

hemani fluroxypyr 200 ec herbicide

hemani australia pty ltd - fluroxypyr as the methyl heptyl ester; liquid hydrocarbon - emulsifiable concentrate - fluroxypyr as the methyl heptyl ester pyridine-pyridinoxy active 200.0 g/l; liquid hydrocarbon solvent other 586.0 g/l - herbicide

Fascinate Dry Herbicide Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fascinate dry herbicide

upl australia pty ltd - glufosinate-ammonium - water soluble granules - glufosinate-ammonium organophosphorus-phosphinic ac active 500.0 g/kg - herbicide

Fascinate 280 SL Herbicide Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fascinate 280 sl herbicide

upl australia pty ltd - glufosinate-ammonium - soluble concentrate - glufosinate-ammonium organophosphorus-phosphinic ac active 280.0 g/l - herbicide

FARM GUARD NU ZINC New Zealand - English - Ministry for Primary Industries

farm guard nu zinc

ixom operations pty ltd - zinc oxide - zinc oxide 990 g/kg - antidote

Farmalinx Swysh 400 EC Herbicide Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

farmalinx swysh 400 ec herbicide

farmalinx pty ltd - fluroxypyr as the methyl heptyl ester; n-methyl-2-pyrrolidone; liquid hydrocarbon - emulsifiable concentrate - fluroxypyr as the methyl heptyl ester pyridine-pyridinoxy active 400.0 g/l; n-methyl-2-pyrrolidone solvent other 100.0 g/l; liquid hydrocarbon solvent other 316.0 g/l - herbicide